Order Article Reprints

Gabbia D, Roverso M, Zanotto I, Colognesi M, Sayaf K, Sarcognato S, Arcidiacono D, Zaramella A, Realdon S, Ferri N, et al. A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH. Marine Drugs. 2022; 20(9):572. https://doi.org/10.3390/md20090572

Gabbia, Daniela, Marco Roverso, Ilaria Zanotto, Martina Colognesi, Katia Sayaf, Samantha Sarcognato, Diletta Arcidiacono, Alice Zaramella, Stefano Realdon, Nicola Ferri, and et al. 2022. "A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH" Marine Drugs 20, no. 9: 572. https://doi.org/10.3390/md20090572

Gabbia, D., Roverso, M., Zanotto, I., Colognesi, M., Sayaf, K., Sarcognato, S., Arcidiacono, D., Zaramella, A., Realdon, S., Ferri, N., Guido, M., Russo, F. P., Bogialli, S., Carrara, M., & De Martin, S. (2022). A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH. Marine Drugs, 20(9), 572. https://doi.org/10.3390/md20090572